## CSX: CSX Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -1.5% below STRENGTH zone (3.0-6.0%); PEG 2.63 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.2% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($35.40)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. CSX Corp. Announces Date for Fourth Quarter Earnings Release and Earnings Call**
- Source: GlobeNewswire | 20251222T140206 | Neutral | Relevance: 100%
- CSX Corp. announced it will release its fourth-quarter financial results after the market closes on Thursday, January 22, 2026. A conference call and live webcast hosted by management will follow at 4:30 p.m. Eastern Time, with details provided for participation. Presentation materials and the webcast will be available on the company's investor relations website.

**2. Aptiv PLC $APTV Shares Purchased by BDF Gestion**
- Source: MarketBeat | 20251220T095635 | Somewhat-Bullish | Relevance: 65%
- BDF Gestion significantly increased its stake in Aptiv PLC by 205.8% during the third quarter, acquiring an additional 18,000 shares to own a total of 26,746 shares valued at approximately $2.31 million. This move is part of broader institutional interest, with other large investors like Boston Partners and Norges Bank also increasing their holdings, resulting in 94.21% of Aptiv stock being owned by hedge funds and institutional investors. Aptiv recently exceeded Q3 earnings and revenue expectations and maintains a "Moderate Buy" consensus analyst rating.

**3. Union Pacific, Norfolk Southern file for merger approval**
- Source: waynecountynews.com | 20251222T150851 | Neutral | Relevance: 64%
- Union Pacific Corp. and Norfolk Southern Corp. have filed their merger application with the Surface Transportation Board (STB), initiating a 30-day review period. The proposed acquisition faces strong opposition from competitors such as BNSF and Canadian Pacific Kansas City, who argue it would harm competition, increase rates, and pose significant risks to the U.S. economy and supply chains. While Union Pacific highlights benefits like improved service and lower costs, the STB will scrutinize the acquisition against strict criteria to determine if it truly serves the public interest, rather than just shareholder profits.

**4. Podcasts that sparked conversation in 2025**
- Source: CHS Inc. | 20251222T170915 | Bullish | Relevance: 63%
- CHS Inc. launched its "It Takes a Co-op™" podcast in 2025, focusing on agricultural, energy, and transportation topics within the cooperative system. This article highlights four key episodes from the year, covering global supply chain adaptation, proactive fertilizer planning, managing agricultural volatility, and the critical role of rail in moving ag products. These episodes feature insights from CHS leaders on how the cooperative system addresses market forces and supports American farmers.

**5. BNSF Urges Federal Scrutiny of Union Pacific–Norfolk Southern Rail Merger**
- Source: Fort Worth Inc. | 20251222T120600 | Neutral | Relevance: 61%
- BNSF Railway is calling for federal regulators to implement heightened scrutiny on the proposed merger between Union Pacific and Norfolk Southern, asserting that the deal would undermine competition, harm shippers, and ultimately lead to higher prices for American consumers. BNSF President and CEO Katie Farmer stated that the transaction poses a significant threat and fails to meet new, tougher merger standards. Union Pacific and Norfolk Southern, however, claim the merger would create America's first transcontinental railroad, strengthen the U.S. supply chain, and offer significant operational benefits.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | Morgan Stanley | $30 | $27 | +11% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 7 ($2.36M) |
| Sells | 3 ($1.78M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 9.3% (-0.4%)
- Blackrock Inc.: 7.6% (-0.8%)
- State Street Corpora: 4.6% (-2.2%)
- Bank of America Corp: 2.3% (+165.7%)
- Geode Capital Manage: 2.3% (-0.2%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.63 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 23%, margin 20%). Analyst sentiment positive (1 raises, avg +11%). Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $68.1B |
| Beta | 1.30 |
| 52W Range | $26.22 - $37.54 |
| Short Interest | 1.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.63 |
| Forward P/E | 19.3 |
| Current P/E | 22.8 |
| YoY Growth | 18.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 1.7% to -1.5% (-3.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.5pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 57. OFD pattern: -DBN (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.46% (CS: 25) | Neutral |
| RSI_14 | 57.2 | Neutral |
| MACD Histogram | 0.00 | Bearish |
| vs SMA20 | 1.011x | Above |
| vs SMA50 | 1.024x | Above |
| vs SMA200 | 1.107x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $36.54
- **Stop Loss:** $35.40 (3.1% risk)
- **Target:** $37.68 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 789
- **Position Value:** $28,830.06
- **Portfolio %:** 28.83%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-01-22 (Est: $0.44)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.42 | $0.37 | -12.9% |
| 2025Q2 | $0.42 | $0.44 | +5.4% |
| 2025Q1 | $0.37 | $0.34 | -6.9% |
| 2024Q4 | $0.42 | $0.38 | -9.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*